A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia von KINON, Bruce J, LU ZHANG, MILLEN, Brian A, OSUNTOKUN, Olawale O, WILLIAMS, Judy E, KOLLACK-WALKER, Sara, JACKSON, Kimberley, KRYZHANOVSKAYA, Ludmila, JARKOVA, Natalia

Volltext

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders von Aigner, Martin, Treasure, Janet, Kaye, Walter, Kasper, Siegfried, Bailer, Ursula, Brambilla, Francesca, Bulik, Cynthia, Athanasios Cordas, Taki, Dardennes, Roland, De Zwaan, Martina, Fernandez-Aranda, Fernando, Fetissov, Serguei, Fichter, Manfred, Halmi, Katherine, Hoek, Hans, Karwautz, Andreas, Kiriike, Nobuo, Lopez-Mato, Andrea, Mendonca Vilela, Joao Eduardo, Mitchell, James, Monteleone, Palmiero, Papezova, Hana, Råstam, Maria, Rihmer, Zoltan, Steiger, Howard, Stein, Daniel, Udristoiu, Tudor, Zechowski, Cezary

Volltext

The microvascular alterations in frontal cortex during treatment with antipsychotics: a post-mortem study von Udriştoiu, Ion, Marinescu, Ileana, Pîrlog, Mihail Cristian, Militaru, Felicia, Udriştoiu, Tudor, Marinescu, Dragoş, Mutică, Mihai

Volltext

Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: Comparison of real-life effectiveness in the treatment of agitation von Castle, David J., Udristoiu, Tudor, Yoon Kim, Chang, Sarosi, Andrea, Pidrman, Vladimir, Omar, A. Nasser, Rosales, Juan Ignacio, Melamed, Yuval, Isik, Turgut, Karagianis, Jamie, Treuer, Tamas

Volltext